No Data
No Data
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
US stock market anomaly | Conduit (CDT.US) soared 130% before the market, reaching a drug licensing agreement with AstraZeneca (AZN.US).
Conduit has reached licensing agreements with Astrazeneca for three experimental therapies.
AstraZeneca Licensing Deal Boosts Conduit Pharma
Express News | Conduit Pharmaceuticals Inc - AstraZeneca to Receive Conduit Stock
Conduit Pharmaceuticals Enters Into Exclusive License Agreement With AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
Express News | EXCLUSIVE: Conduit Pharmaceuticals Tells Benzinga 'Assets Have Shown Favorable Preclinical and Phase I Data. Conduit to Initiate Phase II Clinical Trials'
No Data
102381527 : why you keep spamming ?